全國疫情形勢有何新的變化?國家衛健委迴應
格隆匯3月25日丨國家衛生健康委疾控局副局長、一級巡視員雷正龍介紹,3月1日-24日,全國累計報告本土感染者已超過56000例,波及28個省。其中吉林省疫情仍處於高位水平,3月1-24日,累計報告感染者超過29000例,連續多日每天新增感染人數超過1000例,吉林市和長春市的疫情處於持續發展階段。上海市、河北省、福建省、遼寧省疫情近日快速增長,疫情發生地的社區傳播風險持續存在。山東省青島、威海、淄博,廣東省深圳、東莞等地疫情已得到初步控制。北京市、重慶市、浙江省等地疫情形勢趨於平穩。
雷正龍表示,總的看,目前全國疫情處於攻堅階段,疫情防控形勢仍然嚴峻複雜。國務院聯防聯控機制綜合組繼續指導疫情有關省份從嚴從緊落實各項疫情防控措施,儘快阻斷傳播,防止進一步擴散。沒有發生疫情的地區要壓實各方責任,落實常態化防控各項措施,做好疫情應急處置各項準備,毫不放鬆抓好疫情防控工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.